Stock listing
Gentian Diagnostics Asa
Selected listing: GENT · OSL · NOK · NO
Gentian Diagnostics Asa (Oslo:GENT), Health Technology. Latest release Jul 9, 2026: Gentian Diagnostics : Second quarter 2026 report.
- Ticker
- Oslo:GENT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Oslo
- Currency
- NOK
About Gentian Diagnostics Asa
The company specializes in the development and commercialization of innovative diagnostic solutions. Gentian focuses on enhancing laboratory efficiency and improving patient outcomes through its advanced diagnostic products.
Latest news from Gentian Diagnostics Asa
Gentian Diagnostics : Second quarter 2026 report
July 9, 2026
Gentian Diagnostics - Second quarter 2026 report
July 9, 2026
Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
June 24, 2026
Gentian Diagnostics : Join our R&D Team in Gothenburg
May 28, 2026
Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
May 13, 2026
Research Gentian Diagnostics Asa
Gentian Diagnostics Asa company profile
View the public company page for Gentian Diagnostics Asa on 6ix.
Gentian Diagnostics Asa news
Read company news and market updates connected to Gentian Diagnostics Asa.
Gentian Diagnostics Asa investor events
Find investor webinars, events, and replay context for Gentian Diagnostics Asa.
Alternate listings
GENTO:OMXSTO
SE · NOK
Alternate listing for Gentian Diagnostics Asa; the primary context on this page is GENT:OSL.
A2DLP7:LSX
DE · EUR
Alternate listing for Gentian Diagnostics Asa; the primary context on this page is GENT:OSL.
A2DLP7:LS
DE · EUR
Alternate listing for Gentian Diagnostics Asa; the primary context on this page is GENT:OSL.
6FK:FWB
DE · EUR
Alternate listing for Gentian Diagnostics Asa; the primary context on this page is GENT:OSL.
6FK:DUS
DE · EUR
Alternate listing for Gentian Diagnostics Asa; the primary context on this page is GENT:OSL.
6FK:SWB
DE · EUR
Alternate listing for Gentian Diagnostics Asa; the primary context on this page is GENT:OSL.